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Abstract
Altered cell metabolism is inherently connected with pathological conditions including cancer and viral infections. Kaposi’s
sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi’s sarcoma (KS). KS tumour cells display features of
lymphatic endothelial differentiation and in their vast majority are latently infected with KSHV, while a small number are
lytically infected, producing virions. Latently infected cells express only a subset of viral genes, mainly located within the
latency-associated region, among them 12 microRNAs. Notably, the metabolic properties of KSHV-infected cells closely
resemble the metabolic hallmarks of cancer cells. However, how and why KSHV alters host cell metabolism remains poorly
understood. Here, we investigated the effect of KSHV infection on the metabolic profile of primary dermal microvascular
lymphatic endothelial cells (LEC) and the functional relevance of this effect. We found that the KSHV microRNAs within the
oncogenic cluster collaborate to decrease mitochondria biogenesis and to induce aerobic glycolysis in infected cells. KSHV
microRNAs expression decreases oxygen consumption, increase lactate secretion and glucose uptake, stabilize HIF1a and
decreases mitochondria copy number. Importantly this metabolic shift is important for latency maintenance and provides a
growth advantage. Mechanistically we show that KSHV alters host cell energy metabolism through microRNA-mediated
down regulation of EGLN2 and HSPA9. Our data suggest that the KSHV microRNAs induce a metabolic transformation by
concurrent regulation of two independent pathways; transcriptional reprograming via HIF1 activation and reduction of
mitochondria biogenesis through down regulation of the mitochondrial import machinery. These findings implicate viral
microRNAs in the regulation of the cellular metabolism and highlight new potential avenues to inhibit viral latency.
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Introduction
Viruses are the etiological agents in approximately 12% of
human cancers. Most of these cancers can be attributed to
infections by human papillomavirus (HPV), hepatitis B virus
(HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), and
Kaposi’s sarcoma-associated herpesvirus (KSHV) [1,2]. KSHV is
the etiological agent of Kaposi’s sarcoma (KS) and it is also
causally linked to primary effusion lymphoma (PEL) and a subset
of multicentric Castleman’s disease [3–5]. KSHV, like other
herpesviruses, can enter a latent viral program after multiple
rounds of replication and infection of new target cells [6].
In traditional models of herpesvirus-induced tumorigenesis,
latency has the primary role in oncogenesis, promoting cell
proliferation and impairing apoptosis. The lytic cycle is not
considered to directly contribute to oncogenesis, but plays an
earlier role by allowing viruses to disseminate in the host and to
infect the target cells [6]. Consistently, in KS tumors and in PEL,
the majority of cells are latently infected and express only a subset
of viral genes located within the latency-associated region.
This includes the viral-encoded cyclin (vCyclin), FLIP (vFLIP),
latency-associated nuclear antigen (LANA) and 12 microRNAs
(miRNAs) (to express 17 mature miRNAs) [7–12].
miRNAs are regulatory RNAs expressed by animals, plants and
some viruses [13,14]. They are synthesized as precursors that fold
into imperfect double strand RNA hairpins. This structure is
cleaved in two steps, which are catalysed by Drosha and the
endoribonuclease Dicer RNaseIII nucleases. This process results
in a ,22 base pair miRNA duplex. One strand of this duplex can
be incorporated into the RNA induced silencing complex (RISC)
as a mature miRNA. Within RISC, miRNAs are bound by
Argonaute (Ago) proteins and induce repression of mRNAs
bearing sequences with partial complementary to the miRNA.
Ten out of twelve of the KSHV miRNAs (miR-K12-1 to 9, and
11) are located within the intron of K12 and are expressed as a
cluster [15]. Although the expression levels of these miRNAs varies
between different cells lines and KS samples, it has been
consistently shown that all 10 miRNAs are expressed together in
latently infected cells [16–19].
Recent studies have suggested that approximately half of all
human miRNAs are expressed and function as clusters; targeting
the same mRNA or different mRNAs involved in the same
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pathway [20–22]. Recent cross-linking immunoprecipitation
(CLIP) experiments in PEL cell lines have indicated that this also
might apply to the KSHV miRNAs [16,17]. This suggests that
these miRNAs could have developed in the course of viral
evolution to function as a cluster during latent infection.
The characteristic metabolic hallmark of tumor metabolism is
aerobic glycolysis; In contrast to normal differentiated cells, which
rely primary on mitochondrial oxidative phosphorylation to
generate energy, most cancer cells instead rely on aerobic
glycolysis, a phenomenon termed as the Warburg effect. Cancer
cells metabolism is a result of the modulation of intracellular
signaling pathways that are disrupted by mutated oncogenes and
tumor suppressors. Moreover alteration in cell metabolism may
trigger tumorigenesis [23]. Viruses do not inherently have their
own metabolic output. However, upon infection, viruses dramat-
ically alter the metabolism of the host cell. This can provide
substrates necessary for viral replication and is also likely to be
important for pathogenesis. Human cytomegalovirus (HCMV),
HCV, human immunodeficiency virus (HIV), herpes simplex virus
(HSV) and KSHV have all been shown to alter cell host
metabolism [24–30].
Mitochondria are unique and complex organelles that perform
essential functions in many aspects of cell biology. The dominant
function of mitochondria is the production of more than 90% of
the cell’s energy in the form of ATP through oxidative
phosphorylation (OXPHOS). The oxidative phosphorylation
system consists of four multimeric complexes, coenzyme Q and
cytochrome c forming the mitochondrial respiratory chain (I–IV),
which transfer electrons from reducing equivalents to water,
creating a proton gradient across the inner mitochondrial
membrane, which is used by a fifth complex, the F1F0 ATPase,
to drive the synthesis of ATP [31]. In addition to their role in
energy metabolism, mitochondria also perform various other
functions, which make them absolutely indispensable to the cell.
Among these, mitochondria are implicated in apoptosis, the
regulation of various metabolism pathways, and signal transduc-
tion of antiviral responses [32–34]. This makes them a target of
almost all invading pathogens, including viruses [34]. Although
mitochondria possess a separate and independent genome, most of
the mitochondrial proteins are encoded in the nucleus, translated
in the cytosol and imported into mitochondria [35]. Therefore,
mitochondrial genes are exposed to post-transcriptional regulation
by miRNAs.
The hypoxia-inducible factor 1 alpha (HIF1a) is one of the
master regulators of cell metabolism and was shown to inhibit
mitochondrial biogenesis [36]. Under normoxic conditions,
HIF1a is hydroxylated by the three HIF prolyl hydroxylases
(HPHs) EGLN1-3 (PHD1-3) and this marks it for proteosomal
degradation [37,38]. Under hypoxic condition, the HPHs are
suppressed, and consequently HIF1a is stabilized [38]. Stabilized
HIF1heterodimerizes with HIF1b and binds to the hypoxia
response elements (HREs) in numerous target genes to activate
their transcription [39]. HIF1 is known to mediate an active switch
from oxidative phosphorylation to glycolytic metabolism [40–45].
Although the KSHV genome encodes 12 miRNAs, up to now,
only a handful of their targets have been confirmed [46]. Here we
show that the KSHV miRNAs function as a cluster to induce
metabolic transformation during latent infection from oxidative
phosphorylation to aerobic glycolysis. We identified and confirmed
two specific targets for these miRNAs that suggest a possible
mechanism for this metabolic transformation: the HIF prolyl
hydroxylase EGLN2 and the heat shock protein HSPA9. We also
show that this metabolic conversion contributes to the growth of
latently infected cells under hypoxia and promotes latency
maintenance.
Results
KSHV miRNAs induce a metabolic transformation in LEC
KSHV was shown to induce the Warburg effect in latently
infected endothelial cells, including lymphatic endothelial cells
(LEC), and in KS [24,25]. However, the mechanisms behind these
alterations are not clear, and it is not known whether KSHV has a
direct effect on mitochondrial function.
During latency KSHV expresses only a subset of genes
including vcyclin, vFLIP, LANA and the miRNA cluster. This
suggests that one or more of these genes are responsible for
changing cellular glucose metabolism.
In order to test this hypothesis, we examined the effect of each
of the latent proteins and the miRNA cluster on glucose
metabolism. Metabolic output is known to vary between different
cell types and miRNA function is affected by cell context.
Therefore, we focused on primary dermal microvascular LEC,
which are believed to be the progenitor cells for KS [47–49].
We used lentiviruses to express each of the latent proteins or the
miRNA cluster in LEC (Figure S1A–E). When we expressed the
miRNA cluster, all the individual miRNAs are expressed and
intriguingly the expression level of each one of them is similar to its
expression in KSHV infected LEC (KLEC) (Figure S1E–F). Since
over expression of exogenous miRNAs in cells can have non-
specific effects, we created a mutated version of the miRK12-3,
which is one of the most expressed among the KSHV miRNAs
(Figure S1E and F), and used it as a control for expression of the
KSHV miRNA cluster. There are two obvious characteristics that
indicate a shift in glucose metabolism from oxidative phosphor-
ylation (OXPHOS) to aerobic glycolysis: reduced oxygen
consumption and acidification of growth media due to secretion
of the glycolysis product lactate. We first tested oxygen consump-
tion rate using the Seahorse XF24 analyzer. The Seahorse
Extracellular Flux Analyzer determines oxygen consumption rate
(OCR), and extracellular acidification rate (ECAR), in order to
assess cellular functions such as oxidative phosphorylation and
glycolysis.
While expression of LANA, vcyclin or vFLIP did not have a
significant effect on oxygen consumption (Figure S1G), expression
Author Summary
Kaposi’s sarcoma (KS) is the most common cancer in HIV-
infected untreated individuals. Kaposi’s sarcoma-associat-
ed herpesvirus (KSHV) is the infectious cause of this
neoplasm. The discovery of KSHV and its oncogenic
enigmas has enlightened many fields of tumor biology
and viral oncogenesis. The metabolic properties of KS
significantly differ from those of normal cells and resemble
cancer cells in general, but the mechanisms employed by
KSHV to alter host cell metabolism are poorly understood.
Our work demonstrates that KSHV microRNAs can alter cell
metabolism through coherent control of independent
pathways, a key feature of microRNA-mediated control of
cellular functions. This provides a fresh perspective for how
microRNA-encoding pathogens shape a cell’s metabolism
to create an optimal environment for their survival and/or
replication. Indeed, we show that, in the case of KSHV, viral
microRNA-driven regulation of metabolism is important for
viral latency. These findings will evoke new and exciting
approaches to prevent KSHV from establishing latency and
later on KS.
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of the KSHV miRNA cluster (miR-LEC) reduced base line oxygen
consumption to a similar level to this in KLEC (Figure 1A). In
concordance with this finding we also observed a ,33% increase
of secreted lactate from miR-LEC cells when lactate levels were
measured directly from the growth media (Figure 1B).
Another known marker of aerobic glycolysis is increased glucose
uptake. We monitored glucose uptake into cells by measuring the
uptake of the fluorescently labeled deoxyglucose analog 6-NBDG
and found increased uptake of,30% in cells expressing miR-LEC
(Figure 1C), but not in those expressing latent proteins (Figure
S1J). We also found that the glucose transporter GLUT1 is
overexpressed by over 2-fold in these cells (Figure 1D); a second
indicator of increased glucose uptake.
KSHV express additional two miRNAs out of the cluster; miR-
K10-10 and miR-K12-12. Although these miRNAs expressed in a
relative high levels in KLEC (Figure S1F) we could not find any
significant change in oxygen consumption, lactate secretion or
glucose uptake when expressing these miRNAs in miR-LEC
(Figure S1 H–I and K).
To further rule out unspecific effects caused by expression of a
miRNA cluster we used miR-132/212 cluster as a second control.
As shown in figure 1A and figures S1L–M, expression of this
Figure 1. KSHVmiRNA cluster induces aerobic glycolysis and stabilizes HIF 1 alpha. A. Oxygen consumption rate (OCR) in cells expressing
a non-targeting control vector or the KSHV miRNA cluster was measured using the Seahorse XF24 Analyser. Cells were seeded at a density of 46104
cells per well and the assay was performed according to the manufacturer’s Mito stress protocol. Uncoupled, maximal and non-mitochondrial
respiration was determined after the addition of 5 mM oligomycin, 1 mM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) and 2 mM
antimycin-A. The bar graph presents the average base line OCR in 3 independent experiments relative to non-targeting control OCR (Mean+SEM,
n = 3). B. Lactate levels in the control and miR-LEC culture media. Equal numbers of cells were grown for 24 hours and lactate levels in the media
were measured using the MBL Lactate Colorimetric assay kit. The bar graph presents the average ratio between control and miR-LEC from 3
independent experiments (Mean+SEM, n= 3). C. Glucose uptake into control and miR-LEC cell. Control and miR-LEC were incubated with 30 mM of
the fluorescent glucose analogue 6-NBDG for 20 minutes prior to analysis by fluorescence-activated cell sorter (FACS). The histogram displays one
representative experiment with control shown in black and miR-LEC shown in grey. The bar graph presents the average ratio between the control
and miR-LEC from 3 independent experiments (Mean+SEM, n= 3). D. GLUT1 protein expression, as measured by Western blotting, in control or miR-
LEC. Values indicate the relative signal of the GLUT1 antibody normalized to a-tubulin as measured using the Odyssey. E. HIF1a protein expression, as
measured by Western blotting, in LEC expressing the viral miRNA cluster or the control vector. The bars show relative values of HIF1a antibody
intensity normalized to a-tubulin (Mean+SEM, n = 3). F. Expression of the HIF1a target genes VEGF and ADM. mRNA levels were determined by
quantitative real-time PCR (qRT-PCR). Tubulin beta (TUBB) levels were used for normalization. In all panels statistical significance denoted by *P,.05;
**P,.01; ***P,.001.
doi:10.1371/journal.ppat.1004400.g001
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cluster does not affect oxygen consumption or glucose uptake.
Taken together, these results suggest that the KSHV miRNAs
have the ability to shift host cell metabolism toward aerobic
glycolysis.
The hypoxia-induced factor alpha (HIF1a) is a known regulator
of glucose metabolism [50,51] and can mediate the Warburg effect
in cancer cells [52].
KSHV was also shown to activate HIF1 and HIF2 alpha during
latency [53]. We therefore tested whether the miRNA-induced
alteration in cell metabolism is related to HIF1a expression and
activity. As shown in figure 1E, in miR-LEC HIF1a protein is
overexpressed by ,3 fold compared to the control cells.
Correspondingly, we found increased expression of two known
targets genes of HIF1a: VEGFA (vascular endothelial growth
factor A) and ADM (adrenomedullin) (Figure 1F). This concurred
with increased HIF-1 transcriptional activity as shown by
increased luciferase activity when the miRNAs were expressed
together with a HIF-1 luciferase-reporter assay [54] (Figure S1N).
Taken together these results suggest that expression of the
miRNA cluster in LEC is sufficient to change glucose metabolism
from oxidative phosphorylation to aerobic glycolysis and this
might occur due to HIF1a stabilization.
KSHV miRNAs reduce mitochondrial number
Mitochondria are key players in normal glucose metabolism
in aerobic conditions, and as part of the Warburg effect, many
cancer types show altered mitochondrial activity [55]. Having
found that expression of KSHV miRNAs reduces oxidative
phosphorylation, we next tested their effect on mitochondrial
function. As an initial assessment of mitochondrial function, we
loaded cells with MitoTracker together with Calcein AM.
MitoTracker is a fluorescent dye that labels mitochondria within
live cells utilizing the mitochondrial membrane potential. It
therefore allowed us to calculate mitochondrial volume (Mito-
Tracker staining) relative to total cell volume (Calcein staining).
Although we could not detect any change in mitochondrial
structure, we did find a significant decrease in mitochondria
volume in miR-LEC (Figure 2A). Calculation of mitochondria
volume in KLEC showed again similar reduction to this in miR-
LEC while the miR-132/212 did not have any effect (Figure
S2A). When we tested the expression of miR-K12-10 and miR-
K12-12 in miR-LEC we found again no significant different
(Figure S2B). Since mitochondria have their own independent
genome, one can calculate their number by qPCR analysis using
specific primers for the mitochondrial genome [56]. Total DNA
(mitochondrial and genomic), extracted from miR-LEC and
control cells, was used as template for this analysis. This showed
that while the control cells had between 50–60 copies of the
mitochondrial genome, in miR-LEC there was a 25% decrease
in mitochondrial DNA (Figure 2B). Measuring the expression of
different OXPHOS complexes using an antibody cocktail,
showed a similar decrease in their expression in miR-LEC
(Figure 2C and Figure S2C–D). Next, we examined whether
this reduction in mitochondrial number is due to reduced
mitochondrial biogenesis. For this we measured the mRNA
levels of COX-IV (Cytochrome c oxidase subunit IV) and TFAM
(mitochondrial transcription factor A) as expression of these
genes has been shown to correlate with mitochondrial biogenesis
[57,58]. Using qRT-PCR we found that expression levels of
both genes are significantly decreased by ,20% in miR-LEC
(Figure 2D).
Overall these findings suggest that expression of the miRNA
cluster leads to decreased mitochondrial number and activity.
The KSHV miRNA cluster regulates EGLN2 and HSPA9
miRNAs act to alter the translation and mRNA stability of
specific genes and consequently they regulate the cellular pathways
those genes control. Therefore, we investigated potential genes
that are regulated by the KSHV miRNAs. For this we combined
data from three prediction algorithms (PITA [59], miRanda [60]
and TargetScan [61]), together with published data for the KSHV
miRNAs targetome from two different CLIP experiments [16,17].
This allowed us to identify a number of potential genes that might
be regulated by these miRNAs resulting in altered cellular glucose
metabolism. All three different HIF prolyl hydroxylases (EGLN1-
3) were predicted to be targets of the viral miRNAs. EGLN1 was
suggested to be targeted by miR-K12-2 and miR-K12-11 in both
BC-1 and BC-3 PEL cell lines through a CLIP experiment [16],
while EGLN2 is predicted by the different algorithms to be targets
by multiple miRNAs (miR-K12-2, miR-K12-3, miR-K12-6, miR-
K12-7, miR-K12-8, miR-K12-9 and miR-K12-11).
It has been shown that in different cell types these three HIF
prolyl hydroxylases (HPH) have different expression profiles and
differential functions in the regulation of HIF1a [62]. We
therefore tested the expression profile of these genes in LEC and
found that EGLN2 is the most expressed, whilst EGLN3 is hardly
expressed in LEC (Figure S3A). We next quantified the mRNA
levels of these genes after expression of the viral miRNA cluster
and found that only EGLN2 and EGLN3 were down regulated
(Figure S3B). Taking these findings into consideration, we decided
to focus only on regulation of EGLN2 by the viral miRNAs for
further study.
Interestingly, both previous CLIP studies identified in their
pathway enrichment analysis genes that are involved in protein
targeting and localization[16,17]. In addition, the different
prediction algorithms also predicted many of these genes to be
regulated by the KSHV miRNAs. Since mitochondrial biogenesis
depends on protein translocation, down regulation of proteins
involved in this process might explain the reduced mitochondrial
number and biogenesis induced by KSHV miRNAs. To
investigate this potential regulatory axis, we chose 9 different
genes, predicted to be regulated by the KSHV miRNAs, and
tested their mRNA expression in miR-LEC (Figure S3C). We
found that the mRNA of 5 of these genes was indeed down
regulated in the presence of the KSHV miRNA cluster. In order to
further examine this finding, we cloned the 39UTR of these genes
into a reporter plasmid, downstream of the luciferase coding
sequence. As shown in Figure S3D, these 39UTRs are indeed
targeted by the KSHV miRNA cluster, resulting in decreased
luciferase activity.
As the mitochondrial heat shock protein HSPA9 was suggested
to be a target of multiple viral miRNAs in both CLIP studies (miR-
K12-3 and miR-K12-4) and by all three algorithms (miR-K12-3,
4, 5, 6, 7, 10 and 11), and it was shown to be the most down-
regulated among the genes we tested, we focused on it for further
studies. HSPA9 (mtHSP70, mortalin) is a central subunit of the
matrix-exposed import motor playing a central role in the
mitochondrial translocation system and is essential for efficient
import and export of proteins [63,64]. It was shown that it is
crucial for viability and mitochondrial biogenesis [65,66]. There-
fore, its down regulation could contribute to the reduction of
mitochondria in cells expressing the viral miRNAs.
To confirm that the KSHV miRNA cluster targets EGLN2 and
HSPA9, we measured their expression in miR-LEC. EGLN2 and
HSPA9 mRNA and protein levels were significantly reduced in
miR-LEC comparing to the controls cells (Figure 3A and B and
Figure S3E). To confirm that these miRNAs specifically target the
39UTR of these genes, we used a vector containing the luciferase
Induction of the Warburg Effect by the KSHV miRNAs
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coding sequence up-stream of their 39UTRs. We expressed this
construct in the presence of the miRNA cluster and observed
,50% reduction in luciferase activity, while the control vector
maintained luciferase activity in the presence of the miRNA
cluster (Figure S3F). To confirm these genes are regulated also
during KSHV infection, we tested their expression in KLEC and
found both to be down regulated (Figure S3G).
Next, we tested our hypothesis that the viral miRNAs function
as a cluster, and dissected the contribution of each individual
miRNA to the regulation of EGLN2 and HSPA9. For this we
tested the mRNA levels of EGLN2 and HSPA9 in LEC upon
expression of the separate miRNAs (Figure S3H and figure 3C).
This showed that, as predicted, each one of these genes is targeted
by more than one of the KSHV miRNAs (miR-K12-1, 3, 8, and
11 for EGLN2 and miR-K12-1, 3, 4, 6, 8, 9 and 11 for HSPA9).
Expressing luciferase vectors harboring the 39UTRs of EGLN2 or
HSPA9, together with the individual miRNAs, also showed that
these 39UTRs have target sites for more than one of the KSHV
miRNAs (Figure 3D). Some miRNAs down regulated the mRNA
levels of these genes but did not have any effect on luciferase
activity (e.g. miR-K12-4 on HSPA9). These miRNAs may target
predicted sites outside the 39UTR or regulate ELGN2 and HSPA9
indirectly. Going back to the prediction algorithm PITA for these
genes we found that indeed many of these miRNAs are also
predicted to target these genes either in their 39UTR or coding
sequence (Table S1).
The KSHV miRNA cluster can induce the Warburg effect
through regulation of EGLN2 and HSPA9
To test whether the KSHV miRNAs trigger a shift in cell
metabolism through down regulation of EGLN2 and HSPA9, we
used the human GIPZ shRNAmir lentiviral clones (Open
Biosystems) to specifically suppress each of these genes. We
down-regulated each one of these genes (Figure 4A and Figure
S4A–C) and tested the effect on cellular metabolism in LEC. We
found that knockdown of each of these genes led to stabilization of
HIF1a, decreased oxygen consumption and reduced mitochon-
drial volume (Figure 4A–C). Because knockdown of EGLN2 and
HSPA9 caused HIF1a stabilization, we next investigated whether
the observed metabolic phenotype depends on HIF1a. We
therefore expressed the HIF1a P402A/P564A stable mutant in
LEC [67] (Figure S4D). As shown in Figure 4D–E, expression of
Figure 2. Expression of the KSHV miRNA cluster reduces mitochondrial biogenesis. A. Mitochondrial volume in miR-LEC. Cells were
loaded with 5 mM Calcein-AM and 5 nM MitoTracker Deep Red FM and Z-series of images were. Maximal projections of images were used to quantify
the area of green (Calcein) and red (MitoTracker Deep Red) signals as previously described [88]. Representative single-plane images of the
mitochondrial structure are shown on the left panel. The bar graph on the right presents the average relative mitochondrial volume in miR-LEC
compared to control cells (Mean6SEM, n = 5). B. Mitochondrial DNA (mtDNA) copy number in cells expressing the viral miRNA cluster relative to
control cells. qPCR was carried out as described in [89]. C. Expression levels of the 5 OXPHOS complexes as measured by Western blotting analysis
using the MitoProfile Total OXPHOS Human WB Antibody Cocktail in miR-LEC and the control cells. In all panels statistical significance denoted by
*P,.05; **P,.01; ***P,.001. D. Expression of COXIV and TFAM in cells expressing the KSHV miRNA cluster relative to control cells. mRNA levels were
determined by qRT-PCR. TUBB levels were used for normalization.
doi:10.1371/journal.ppat.1004400.g002
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this mutant resulted in a similar decrease in oxygen consumption
and mitochondrial volume as that caused by EGLN2 and HSPA9
silencing, suggesting that HIF signaling is playing a role in this
phenotype.
To further examine whether this metabolic transformation
depends on EGLN2 and HSPA9, we next tested whether
overexpression of these proteins could counteract the effect of
the miRNA cluster. We achieved overexpression of both EGLN2
and HSPA9, alongside viral miRNA expression, by using
constructs that lacked 39UTRs (Figure S5A). Expression of each
miRNA-resistant gene reversed the effect of the viral miRNAs on
its particular mRNA but not on the other gene’s mRNA (Figure
S5B), showing that the miRNA cluster down-regulates these genes
independently.
As expected, overexpression of EGLN2 prevented HIF1a
stabilization by the miRNA cluster (Figure 5A). More impor-
tantly, we found that both EGLN2 and HSPA9 overexpression
significantly reduced the effect of the viral miRNA cluster on
oxygen consumption and mitochondrial volume (Figure 5B and
C). Interestingly, EGLN2 up-regulation had a bigger effect on
both oxygen consumption (Figure 5B), and mitochondrial
volume (Figure 5C), when compared to HSPA9 overexpression.
When both proteins were overexpressed together, they showed
an additive effect. The fact that the miRNA cluster phenotype
could not be fully reversed by overexpression of either EGLN2
alone, HSPA9 alone, or the combination of both proteins,
suggests that although they are part of the miRNA-induced
metabolic transformation mechanism, other genes also play a
role.
Inducing the Warburg effect provides a growth
advantage in low oxygen conditions and is important for
latency maintenance
Increased glycolytic flux, together with HIF1a stabilization,
suggests that latent cells might be more adaptable to low oxygen
conditions. We therefore tested whether miR-LEC proliferate
faster than the control cells when subjected to such conditions.
Cells were grown in high oxygen (20%) and then moved to 1.5%
oxygen and analyzed after 24, 48 and 72 hours. In contrast to high
oxygen conditions, where both control and miR-LEC growth rates
were similar (Figure S6A), when cells were exposed to hypoxia,
miR-LEC had a significant growth advantage in the first 24 hours
(Figure 6A). This difference was less significant after 48 and
72 hours, suggesting that by these time points the control cells had
adjusted to the low oxygen conditions. When we tested the effect
of knocking down EGLN2 and HSPA9, we found that only
EGLN2 silencing improved the initial response of LEC to hypoxia
(Figure 6B and Figure S6B).
There is evidence that in vitro three-dimensional (3D) cell
cultures more accurately reflect the complex in vivo microenvi-
ronment than simple two-dimensional cell monolayers. We
therefore explored the effect of the KSHV miRNAs on cell
growth under these conditions. To do this we used the recently
published microplate-based method to create and measure
spheroid growth [68]. To investigate the effect of the KSHV
miRNAs in this context, we chose the human osteosarcoma U2OS
cell line, which has previously been shown to form spheroids using
this method. U2OS were infected with lentiviruses to express the
miRNA cluster or the specific hairpins for EGLN2 and HSPA9
Figure 3. The KSHV miRNA cluster regulates EGLN2 and HSPA9. A. Relative mRNA levels of EGLN2 and HSPA9 in miR-LEC compared to
control cells. mRNA levels were determined by qRT-PCR. TUBB levels were used for normalization. B. Protein levels of EGLN2 and HSPA9 in miR-LEC.
Top right panel: protein expression, as measured by Western blotting, in miR-LEC and the control cells. C. Relative mRNA levels of EGLN2 and HSPA9
in LEC expressing the individual KSHV miRNAs. mRNA levels were determined by qRT-PCR. TUBB levels were used for normalization. D. Reporter assay
indicating the sensitivity of the EGLN2 or HSPA9 39UTRs to targeting by the individual KSHV miRNAs. Firefly expression was normalized to Renilla
expression to give the relative light units (RLU), which are shown relative to the non-targeting control. In all panels statistical significance denoted by
*P,.05; **P,.01; ***P,.001.
doi:10.1371/journal.ppat.1004400.g003
Induction of the Warburg Effect by the KSHV miRNAs
PLOS Pathogens | www.plospathogens.org 6 September 2014 | Volume 10 | Issue 9 | e1004400
knockdown. As in LEC, expression of the KSHV miRNA cluster
in U2OS led to up-regulation of HIF1a and down regulation of
EGLN2 and HSPA9 (Figure S6C). These cells were then plated in
ultra-low attachment 96-well round-bottomed plates as previously
described [68]. Spheroid growth was measured using the
CellTiter-Glo Luminescent Cell Viability Assay (Promega) and
spheroid area was measured using the EVOS cell imaging system.
We found that, similarly to the growth advantage under hypoxic
conditions, expression of the KSHV miRNA cluster and knock
down of EGLN2 led to enhanced growth in 3D cultures, as shown
by increased spheroid area (Figure S6D–E) and cell number
(Figure 6F).
The fact that KSHV has evolved to alter cellular metabolism
and to reduce mitochondrial biogenesis during latency suggests
that these phenomena have a function during the life cycle of the
virus.
We therefore examined the importance of reduced mitochon-
drial biogenesis for latency maintenance. To test this, we treated
Figure 4. Down regulation of EGLN2 and HSPA9 phenocopies miRNA cluster expression. A–C. LEC were infected with specific hairpins for
EGLN2 and HSPA9 and a non-targeting control (Open Biosystems) and analyzed for: A. Protein expression levels of HIF1a, HSPA9 and EGLN2, as
measured by Western blotting; B. Base line OCR (as described in Figure 1A); C. Mitochondrial volume (as described in Figure 2A). D–E. LEC were
infected with lentiviruses for HIF1a P402A/P564A (mut HIF1a) and analyzed for base line OCR (D) and mitochondrial volume (E).
doi:10.1371/journal.ppat.1004400.g004
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the latently infected PEL cell line BCBL1 with Resveratrol, which
has been shown to induce mitochondrial biogenesis in some cell
types [69,70]. We found that in PEL cells, Resveratrol treatment
leads to increased expression of COX-IV and the OXPHOS
complexes (Figure 6C–D), in a dose dependent manner. Striking-
ly, this increase in mitochondrial biogenesis caused extensive cell
death (Figure 6E). When we tested for viral gene expression we
found that Resveratrol treatment caused substantial expression of
lytic genes (Figure 6F), suggesting that the Resveratrol-induced cell
death is due to induction of the lytic cycle in these cells. In order to
directly test for viral production we used the media from
Resveratrol induced cells to directly infect 293T cells and
measured the KSHV copy number in these cells. As shown in
figure 6G, infection using media from cells treated with Resver-
atrol leads to increase of up to ,15 times of KSHV copy number
in the infected cells.
In order to determine if the same holds true in primary infected
cells, we used the recombinant virus, rKSHV.219, which expresses
a red fluorescent protein under the KSHV lytic PAN promoter
[71]. This virus can establish a latent infection in LEC, making it a
valuable model for the study of latency and reactivation. We
selected infected LEC to create KLEC.219, as previously
described [71], and treated them with Resveratrol to induce
mitochondrial biogenesis. We first confirmed that Resveratrol does
not have a toxic effect on LEC and that it induced mitochondrial
biogenesis in them (Figure S7A and B). Resveratrol treatment led
to extensive KSHV reactivation, as indicated by a 42% increase in
RFP positive cells (Figure 6H and Figure S7C). Interestingly,
when we overexpressed EGLN2 and HSPA9 in BCBCL1 and
KLEC.219, we found that while HSPA9 did not show a significant
effect, EGLN2 overexpression caused a small increase in lytic
phase activation (Figure S7D and F). Respectively, knocking down
HIF1a gave similar results; activation of the lytic phase indicated
by increase in RFP positive cells and KSHV copy number in cell
infected with media from these cells (Figure S7 E–F).
These results suggest that reduced mitochondrial activity is
important for maintaining latency in KSHV infected cells.
Discussion
KSHV has been shown to highjack and manipulate various
cellular pathways to promote its own survival and spread [72].
Among those it was shown that KSHV alter its host cell energy
metabolism, but neither the mechanism by which this is achieved
nor the biological benefit, are understood. Our study has revealed
a functional role for the KSHV miRNAs in the regulation of cell
metabolism. We report that expression of the KSHV miRNA
cluster, in primary LEC, induces the Warburg effect; it reduces
oxygen consumption, increases lactate secretion, increases glucose
uptake and reduces mitochondrial biogenesis. In addition,
Figure 5. Overexpression of EGLN2 and HSPA9 partially rescues the miRNA cluster effect on glucose metabolism. A. HIF1a levels as
measured by Western blotting in miR-LEC with or without overexpression of EGLN2 (EV= empty vector). B. Base line OCR was measured using the
Seahorse XF24 Analyser in miR-LEC, with or without overexpression of EGLN2 and HSPA9 (as described in Figure 1A). C. Mitochondrial volume was
measured as described in Figure 2A.
doi:10.1371/journal.ppat.1004400.g005
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expression of these miRNAs also leads to stabilization and
activation of the transcription factor HIF1a, a master regulator
of cell metabolism.
We identified and confirmed two new targets for the KSHV
miRNAs, EGLN2 and HSPA9, and show that KSHV alters
host cell energy metabolism through down-regulation of these
genes. Nevertheless, the fact that overexpression of these genes
(without their 39UTRs) did not fully rescue the phenotypic
effect of these miRNAs, suggests that there are more genes
involved in this metabolic transformation. This is not
surprising because the miRNAs within the cluster are predicted
to target many other genes, some of which are involved in
cell metabolism, and these might also contribute to this
phenomenon.
We suggest a two-armed mechanism by which KSHV changes
cellular energy metabolism; the first is based on activation of the
transcription factor HIF and the subsequent up-regulation of its
metabolically relevant target genes. The second arm directly
reduces mitochondrial biogenesis by impairing the import of
proteins into mitochondria (Figure 7).
We show that the KSHV miRNAs induced-metabolic shift
contributes to infected cells proliferation in low oxygen and is
important for latency maintenance. KS and PEL cells are not
exposed to extensive hypoxia and KSHV associated solid
lymphomas are rare. Nevertheless, in some cases KS can have a
solid mass [73], or PEL develops in hypoxic niches, as was shown
in an artificial cavity related to the capsule of a breast implant
[74]. In addition, adjustments to energy metabolism have been
Figure 6. The miRNAs induced metabolic shift enhanced growth under hypoxia and is important for latency maintenance. A–B. 7500
cells expressing the KSHV miRNA cluster or the control vector (A) and cells expressing the non-targeting control or shEGLN2 (B) were plated in 96 well
plates. Cells were fixed after 30 minutes, 24, 48 and 72 hours using 10% Trichloroacetic acid, stained with Sulforhodamine B, and plates were read at
564 nm. Optical density indicates the amount of proteins in the different wells. C. Expression of COXIV in BCBL1 cells treated with in indicated
concentration of Resveratrol. mRNA levels were determined by qRT-PCR. TUBB levels were used for normalization. D. Expression of the 5 OXPHOS
complexes, as measured by Western blotting analysis using the MitoProfile Total OXPHOS Human WB Antibody Cocktail in BCBL1 cells treated with
the indicated concentration of Resveratrol. Values indicate the relative signal of the different antibodies normalized to HSP90 as measured using the
ImageQuant software. E. BCBL1 cells were treated with the indicated concentration of Resveratrol for 48 hours. Viability was determined using the
Muse Count & Viability Assay Kit on the Muse cell analyzer (Merck Millipore). F. Relative mRNA levels of the KSHV lytic genes ORF65 and K8.1 in BCBL1
cells treated with Resveratrol or TPA for 48 hours. mRNA levels were determined by qRT-PCR. TUBB levels were used for normalization. G. Relative
KSHV DNA copy number in 293T cells infected using the growth media of BCBL1 cell treated with the incubated concentration of Resveratrol. H. LEC
were infected with rKSHV.219 virus and selected as previously described [71]. Cells were treated with Resveratrol and analyzed by Flow cytometer
after 72 hours. The numbers denote the percentage of RFP positive cells, which reflects lytic cells.
doi:10.1371/journal.ppat.1004400.g006
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suggested to give cancer cells many advantages with respect to
proliferation and growth. The prevalent theory is that, although
aerobic glycolysis is an inefficient way to generate energy, it is a
necessary adaption to facilitate the uptake and incorporation of
nutrients into the biomass, which is needed to produce new cells.
This modification also offers similar advantages for KSHV-
infected cells.
We have shown here for the first time that the KSHV miRNAs
regulate cell metabolism. Nevertheless, regulating energy and
cancer metabolism using miRNAs is not exclusive to viruses, and
cellular miRNAs are also known to control energy metabolism. As
we show for the KSHV miRNAs, cellular miRNAs also participate
in manipulating cancer cell metabolism by regulating the
expression of genes with protein products that either directly
regulate the metabolic machinery or indirectly modulate the
expression of metabolic enzymes, serving as master regulators [75–
78].
Various types of cancer cells have been shown to overexpress
HIF due to intratumoral hypoxia or as a result of genetic
alterations that have occurred as part of their oncogenic program
(reviewed in [79–82]). We show a new miRNA-based mechanism
by which KSHV regulates HIF1a levels in cells. The algorithm
miRror [83] suggests that there are 35 cellular miRNAs predicted
to target EGLN2 (table S2) and 14 (table S3) predicted to target all
three HIF prolyl hydroxylases. This suggests that a similar
miRNA-based regulation mechanism of HIF1a stability might
exist in normal or cancerous cells.
All previously performed AGO2 CLIP experiments in PEL,
several different prediction algorithms and our results suggest that
the KSHV miRNAs target HSPA9, together with other proteins
from the mitochondrial import machinery. We confirm that
several of the KSHV miRNAs collaborate to target HSPA9 and
consequently reduce mitochondrial activity. Very little is known
about how cells regulate import into mitochondria and whether
this might be a mechanism through which mitochondrial
biogenesis and activity is regulated. Saccharomyces cerevisiae,
which do not have miRNAs, regulate import into mitochondria
using cytosolic kinases [84]. We propose a possible regulation of
the mitochondrial import machinery by miRNAs. Our results
suggest the KSHV miRNAs regulates key proteins in this import
machinery such as HSPA9, TOMM40, TOMM22 and others.
This could be the reason that over expression of EGLN2 and
HSPA9 failed to rescue the miRNAs phenotype, since other
proteins from the import machinery are still down regulated.
Regulation of this process by miRNAs could allow fine-tuning of
mitochondrial activity, which could be rapidly reversed. It has
been previously shown that knockout of the mitochondrial HSP70
(HSPA9), as well as other essential proteins in the import
machinery, is lethal to cells. Thus, fine-tuning achieved by
miRNAs can allow viruses to reduce mitochondrial oxidative
phosphorylation while keeping its host cell alive.
Our findings provide further support, in the context of cell
metabolism, for the concept that KSHV miRNAs operate as a
functional cluster. We show that KSHV miRNAs are expressed
together in infected cells and collaborate to regulate specific genes
(e.g. EGLN2 and HSPA9) within specific pathways (e.g. the
mitochondria import machinery). With regards to individual
mRNA targets we observe synergy but also some redundant
targeting. However, we find that no individual miRNA can fully
reproduce the effect of the whole KSHV miRNA cluster on
metabolism, suggesting that these miRNAs function synergistical-
ly. Moreover, the fact that they are not all expressed to same level
suggests an internal regulation of their expression. We speculate
that by expressing this cluster, the virus circumvents one of the
host cell’s main evolutionary tools for escaping unwanted miRNA
targeting: alterations in 39UTR sequences. Even if one miRNA
target site is lost, the remaining miRNAs are still able to bind to
and regulate the transcript. Although the specific contribution of
each of the KSHV miRNAs to this phenomenon has not yet been
dissected, through suppressing expression of multiple genes within
a specific cellular pathway, the overall effect of the miRNA cluster
is coherent, robust and quantitatively sufficient to lead to
functionally relevant outcomes. Interestingly, this functional
clustering of viral miRNAs around cellular metabolism seems to
be conserved in other herpesviruses. EBV, also a gamma-
herpesvirus, which expresses multiple viral miRNAs, regulates
many of the same genes and cellular pathways as KSHV. Notably,
an AGO2 CLIP experiment [16] pulled HSPA9, together with
other proteins involved in import into mitochondria, as targets of
the EBV miRNAs, suggesting potential functional convergence.
KSHV-infected cells share many characteristics with cancer
cells, in particular altered energy metabolism. Therefore, in
addition to the implications for KS biology, KSHV infection could
be used as a model to study the role of the Warburg effect (and
other altered metabolic pathways) during transformation.
Although having a growth advantage in hypoxic conditions may
be significant in certain environments, we speculate that the main
evolutionary benefit gained by KSHV through alteration of
cellular metabolism is the generation of optimal intracellular
conditions for latency establishment and maintenance. Our results
show that inducing mitochondria biogenesis interferes with the
virus ability to maintain latency - a key step in the virus oncogenic
program. Consequently these findings have translational-medicine
Figure 7. A two-armed mechanism model by which KSHV
changes cellular energy metabolism. KSHV microRNAs induce a
metabolic transformation by concurrent regulation of two independent
pathways; transcriptional reprograming via HIF1 activation and
reduction of mitochondria biogenesis through down regulation of the
mitochondrial import machinery.
doi:10.1371/journal.ppat.1004400.g007
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implications with regards to KSHV-associated malignancies, but
also in the broader context of pathologies etiologically linked to
DNA viruses.
Materials and Methods
Cell culture
LEC were purchased from Promocell and grown in endothelial
growth medium MV2 (Promocell). LEC were used for experi-
ments before passage 8. BCLB-1 cells latently infected with
recombinant GFP-KSHV [47] were cultured in RPMI 1640
(Invitrogen) supplemented with 10% FCS and 400 ng/mL
Geneticin (Invitrogen). 293T, U2OS and Vero cells were grown
in DMEM (Invitrogen), supplemented with 10% FBS.
Plasmids
The KSHV miRNA cluster and individual miRNAs were
cloned into the lentiviral vector pSIN-MCS as previously
described [18]. The cluster and individual miRNAs were
subcloned into the gateway entry vector pENTR/pTER+ [85].
These miRNAs were further cloned into the 3rd gen lentiviral
promoter-less Gateway destination vectors pLenti X1 Puro DEST
and pLenti CMV GFP DEST using the Gateway LR Clonase II
enzyme mix (Invivogen). HSPA9 was amplified using specific
primers (Table S4) and cloned into pENTR4. The gene was
further cloned into pLenti PGK Puro Dest [85] using the Gateway
LR Clonase II enzyme mix (Invitrogen). FLAG-EglN2-pLenti6
was as previously described [85].
Lentivirus production and infection of LEC
Vesicular stomatitis virus-G envelope-pseudotyped lentiviral
virions were produced by cotransfecting 6 mg lentiviral construct,
3 mg p8.91, and 1 mg pMD.G into a 10-cm dish of ,70%
confluent 293T cells using the FuGENE (Roche) protocol. Five
hours after transfection, the medium was changed, and 48 h after
transfection, the medium containing the lentiviral virions was
collected, passed through a 0.45 mm filter, and either aliquoted
directly or concentrated and stored at280uC. Lentiviral infections
were done by incubating the desired amount of virus preparation
with suspension LEC for 5 h, after which the medium was
changed.
Titration of each lentivirus preparation was done either by
quantitative PCR [86] or Flow cytometry [87]. All experiments
were performed in infected LEC showing more than 80% positive
cells.
Basal cellular respiration rate
Cells were seeded in XF 24-well cell culture microplates
(Seahorse Bioscience) at 46104 cells/well (0.32 cm2) in 200 ml
growth medium and then incubated at 37uC/5% CO2 for 20–
24 hours. Assays were initiated by removing the growth medium
from each well and replacing it with 600 ml of assay medium pre-
warmed to 37uC. The cells were incubated at 37uC for 30 minutes
to allow media temperature and pH to reach equilibrium before
the first rate measurement. Prior to each rate measurement, the
XF24 Analyzer gently mixed the assay media in each well for
3 min to allow the oxygen partial pressure to reach equilibrium.
Following mixing, OCR and ECAR were measured simulta-
neously for 4 min to establish a baseline rate. The assay medium
was then gently mixed again for 3 min between each rate
measurement to restore normal oxygen tension and pH in the
microenvironment surrounding the cells. Uncoupled, maximal
and non-mitochondrial respiration was determined after the
addition of 5 mM oligomycin, 1 mM carbonyl cyanide 4-(trifluor-
omethoxy)phenylhydrazone (FCCP) and 2 mM antimycin-A. All
chemicals were from Sigma-Aldrich.
Western blotting and antibodies
Cells were lysed in RIPA buffer (300 mM Sodium Chloride, 1%
NP-40, 0.5% Sodium deoxycholate, 0.1% Sodium dodecyl
sulphate and 50 mM Tris pH 8.0). Equal amounts of protein
were resolved on Mini-PROTEAN TGX Precast gels (Bio-Rad
Laboratories). Antibodies against EGLN2 (Novus Biologicals),
HSPA9 (Abgent), GLUT1 (Alpha Diagnostic), HSP90 (Cell
signaling), a-tubulin and Flag (Sigma-Aldrich) were detected with
IRDye secondary antibodies (LI-COR). Antibodies against HIF1a
(BD Transduction Laboratories) and the MitoProfile Total
OXPHOS Human WB Antibody Cocktail (Abcam) were detected
with HRP-conjugated secondary antibodies and were quantified
using ECL (GE Healthcare). Images were analysed using the
Image Studio Lite (LI-COR) or the ImageQuant (GE) Western
blot analysis softwares.
qPCR and qRT–PCR
Genomic DNA for qPCR was extracted using the QIAamp
DNA mini-kit (Qiagen). Total RNA was extracted using either the
RNeasy mini-kit or the miRNeasy mini-kit (Qiagen). Approxi-
mately 100 to 1000 ng of total RNA was used for cDNA synthesis
using the ProtoScript II Reverse Transcriptase (New England
Biolabs). DNA and mRNA levels were quantified by qPCR and
qRT-PCR using optimized primers (Table S4) and SYBR Green
PCR master mix (Applied Biosystems). qRT-PCR quantification
of VEGF and ADM was performed using Taqman gene
expression assays (Applied Biosystems).
cDNA synthesis for qRT–PCR quantification of mature
miRNAs was performed using the Exiqon Universal cDNA
Synthesis Kit II according to the manufacturer’s instructions.
Detection of the mature KSHV miRNAs was performed using the
kshv-miR LNA PCR primer sets (Exiqon). Cellular small nucleolar
RNA RNU66 was used as a reference RNA.
Cell count and viability
Cells were counted and analyzed for viability using the Muse
Count & Viability Reagent on the Muse Cell Analyzer (Merck
Millipore).
Glucose uptake
Glucose uptake was measured by incubating cells with 30 mM
glucose analogue 6-NBDG (Invitrogen) for 15 minutes. Cells
where then washed and trypsinized and their fluorescence (lex:
465 nm, lem: 540 nm) was measured by flow cytometry.
39UTR luciferase reporter assay
The 39UTRs of the indicated genes were amplified using
specific primers (Table S4) and cloned into the psiCHECK 2
vector (Promega). The reporter plasmids (50 ng) were transfected
into 293T cells, 48 hours after transfection with the individual
miRNAs or the miRNA cluster. Cells were harvested 24 hours
after transfection according to the Dual-Luciferase Reporter assay
system (Promega). Luciferase activity was measured using a
Fluoroskan Ascent FL luminometer (ThermoScientific). Firefly
activity was normalized to internal Renilla luciferase levels.
HRE luciferase reporter assay
U2OS-HRE-luc cells were infected with the control or the
miRNA cluster vector. 72 hours post infection cells were washed
twice with ice-cold PBS and lysed using Glo Lysis buffer
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(Promega). Luciferase activity was measured using the steady Glo
Luciferase assay (Promega).
Mitochondrial structure and volume
Cells were loaded with 5 mM Calcein-AM and 50 nM
MitoTracker Red (Invitrogen; 37uC, 30 minutes) in growth media
for 30 minutes and Z-series of images were acquired using a Zeiss
LSM 510 system (Carl Zeiss, Inc., Cambridge, UK), as previously
described [88]. Maximal projection of images was used to quantify
the area of green (Calcein) and red (mitoTracker Red) signal.
Mitochondrial area was defined relative to cytoplasmic area as
‘area red/area green’. Images were analyzed using the Meta-
Morph Microscopy Automation & Image Analysis Software
(Molecular Devices). The two channels (Calcein-AM and Mito-
Tracker Red) were separated and threshold in order to acquire
two separate binary images.
KSHV preparation and establishment of stable infections
rKSHV.219 stocks were prepared from the Vero cell as
previously described [71]. Stably infected LEC were selected
and maintained with 1 ug/ml puromycin (Invivogen).
SRB assay
Cells were grown in 96well plates and fixed using cold 10%
Trichloroacetic acid for 1 hour at 4uC. Wells were then washed 5
times with distilled water and left to air dry before staining with of
0.4% w/v Sulforhodamine B (Sigma-Aldrich) for 30 minutes at
room temperature. Wells were washed 5 times with 1% v/v acetic
acid and left to air dry before adding 100 ml of 10 mM Tris base
pH 10.5. Plates were incubated on a plate shaker for 5 minutes
and read at 564 nm using the Varioskan Flash plate reader
(Thermo Scientific).
Generation and analysis of spheroids
For spheroid generation, 200 ml of cell suspension (16104 cells/
ml) were dispensed into ULA 96-well round-bottomed plates
(Corning) using a multichannel pipette. Plates were incubated for 4
days at 37uC, 5%CO2. Images were acquired by EVOS cell
imaging system and analysed using the Adobe Photoshop CS6
extended version.
Supporting Information
Figure S1 KSHV miRNA cluster induces aerobic glycol-
ysis and stabilizes HIF 1 alpha. LEC, infected with lentivirus
expressing LANA, vcyclin, vFLIP or the miRNA cluster, were
harvested 72 hours post-infection. A–D. Relative mRNA levels
(DCt) for LANA, vcyclin and vFLIP were determined by
quantitative real-time PCR (qRT-PCR). Expression was measured
relative to the TUBB. E–F. cDNA synthesis was performed using
the Exiqon Universal cDNA Synthesis Kit II. Detection of the
mature KSHV miRNAs was performed using the KSHV-miR
LNA PCR primer sets (Exiqon). Expression was measured relative
to the cellular small nucleolar RNA RNU66. G. OCR of cells
expressing the different components of the oncogenic cluster was
measured using the Seahorse XF24 Analyzer. Cells were seeded at
density of 46104 cells per well and the assay was performed
according to the manufacturer’s protocol. Uncoupled, maximal
and non-mitochondrial respiration was determined after the
addition of 5 mM oligomycin, 1 mM carbonyl cyanide 4-(trifluor-
omethoxy)phenylhydrazone (FCCP) and 2 mM antimycin-A. H.
Base line OCR was measured using the Seahorse XF24 Analyser
in Control, miR-LEC and miR-LEC expressing also miR-K10-12
and miR-K12-12. I. Lactate levels in the control and miR-LEC
culture media. Equal numbers of cells were grown for 24 hours
and lactate levels in the media were measured using the MBL
Lactate Colorimetric assay kit. The bar graph presents the average
ratio between control and miR-LEC from 3 independent
experiments (Mean+SEM, n= 3). J–L. Glucose uptake into:
LEC expressing the different components of the oncogenic cluster
(J), miR-LEC and miR-LEC expressing also miR-K12-10 and
miR-K12-12 (K) and LEC expressing the miR-132/212 cluster
(L). Cells were incubated with 30 mM of the fluorescent glucose
analogue 6-NBDG for 20 minutes prior to analysis by fluores-
cence-activated cell sorter (FACS). M. Base line OCR was
measured using the Seahorse XF24 Analyser in Control, LEC
expressing the miR-132/212 cluster and miR-LEC. N. U2OS-
HRE-luc cells were infected with the control or the miRNA cluster
vectors. 72 hours post infection cells were washed twice with ice-
cold PBS and lysed using Glo Lysis buffer (Promega). Luciferase
activity was measured using the steady Glo Luciferase assay
(Promega) according to the manufacturer’s instructions.
(TIF)
Figure S2 Expression of the KSHV miRNA cluster
reduces mitochondrial biogenesis. A–B. Mitochondrial
volume in miR-LEC. Cells were loaded with 5 mM Calcein-AM
and 5 nM MitoTracker Deep Red FM and Z-series of images
were. Maximal projections of images were used to quantify the
area of green (Calcein) and red (MitoTracker Deep Red) signals as
previously described [88]. The bar graph on the right presents the
average relative mitochondrial volume in miR-LEC compared to
control cells (Mean6SEM, n= 3). C. Expression levels of the 5
OXPHOS complexes as measured by Western blotting analysis
using the MitoProfile Total OXPHOS Human WB Antibody
Cocktail in LEC expressing either a control vector or the viral
miRNA cluster. The left and right panels are two exposures of the
same Western blot presented in figure 2. D. Relative values of
different MitoProfile antibodies. The graph presents the total
intensities of the different detected antibodies normalized to
HSP90 (Mean+SEM, n= 3).
(TIF)
Figure S3 The KSHV miRNA cluster regulates EGLN2
and HSPA9. A. Expression levels of EGLN1, EGLN2 and
EGLN3 in primary LEC. mRNA levels were determined by qRT-
PCR. Tubulin beta (TUBB) levels were used for normalization. B.
Relative mRNA levels of EGLN1, EGLN2 and EGLN3 in miR-
LEC compared to control cells. mRNA levels were determined by
qRT-PCR. TUBB levels were used for normalization. C. Relative
mRNA levels of 9 genes from the mitochondrial import machinery
in miR-LEC compared to control cells. mRNA levels were
determined by qRT-PCR. TUBB levels were used for normali-
zation. D. Reporter assay indicating the response of HSPD1,
TOMM22, TOMM40 and TIMM23 39UTRs to the KSHV
miRNA cluster. Firefly expression was normalized to Renilla
expression to give the relative light units (RLU), which are shown
relative to the non-targeting control. E. Relative protein
expression for EGLN2 and HSPA9 from 3 independent
experiments were calculated according to the signal measured
using the Odyssey (Mean+SEM, n= 3). F. Reporter assay
indicating the sensitivity of the EGLN2 or HSPA9 39UTRs to
targeting by the KSHV miRNA cluster (Mean+SEM, n= 3).
Firefly expression was normalized to Renilla expression to give the
relative light units (RLU), which are shown relative to the non-
targeting control. In all panels statistical significance denoted by
*P,.05; **P,.01; ***P,.001. G. Relative mRNA levels of
EGLN2 and HSPA9 in KLEC compared to control cells. mRNA
levels were determined by qRT-PCR. TUBB levels were used for
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normalization. H. Expression of the mature KSHV miRNAs
when expressed in LEC individually. Detection of the mature
KSHV miRNAs was performed using the KSHV-miR LNA PCR
primer sets (Exiqon).
(TIF)
Figure S4 Expression levels of EGLN2, HSPA9 and the
HIF1 alpha P402A/P564A stable mutant. A–B. Relative
mRNA levels of EGLN2 (A) and HSPA9 (B) in LEC infected with
specific hairpins for EGLN2 and HSPA9 (Open Biosystems).
mRNA levels were determined by qRT-PCR. TUBB levels were
used for normalization. C. Relative protein expression for EGLN2
and HSPA9 from 3 independent experiments were calculated
according to the signal measured using the Odyssey (Mean+SEM,
n=3). D. HIF1 alpha protein expression, as measured by Western
blotting, in LEC infected with lentivirus expressing the HIF1 alpha
P402A/P564A stable mutant.
(TIF)
Figure S5 Overexpression of EGLN2 and HSPA9 par-
tially rescues the miRNA cluster effect on glucose
metabolism. A. Protein expression, as measured by Western
blotting using anti Flag antibody, in miR-LEC infected with
lentivirus expressing either EGLN2-Flag or HSPA9-Flag. B.
Relative mRNA levels of EGLN2 and HSPA9 in miR-LEC
expressing EGLN2-Flag or HSPA9-Flag. mRNA levels were
determined by qRT-PCR. TUBB levels were used for normali-
zation.
(TIF)
Figure S6 The miRNAs induced metabolic shift en-
hanced growth under hypoxia and in 3D culture. A–B.
7500 cells expressing the KSHV miRNA cluster or non-targeting
control (A) and cells expressing the shControl or shEGLN2 (B)
were plated in 96 well plates. Cells were fixed after 30 minutes, 24,
48 and 72 hours using 10% Trichloroacetic acid, stained with
Sulforhodamine B, and then plates were read at 564 nm. Optical
density indicates the amount of proteins in the different wells. C.
Protein expression, as measured by Western blotting, in selected
U2OS cells expressing the KSHV miRNA cluster.D–F. 5000 cells
of each condition were plated in ultra-low attachment 96-well
round-bottomed plates. Spheroids were imaged at day 5,9 and 14
and analyzed using Adobe Photoshop CS6 for spheroid area (D–
E), or harvested using CellTiter-Glo Luminescent Cell Viability
Assay (F).
(TIF)
Figure S7 The miRNAs induced metabolic shift is
important for latency maintenance. A. LEC were treated
with the indicated concentration of Resveratrol for 48 hours.
Viability was determined using the Muse Count & Viability Assay
Kit on the Muse cell analyzer (Merck Millipore). B.Mitochondrial
DNA (mtDNA) copy number in cells treated with the indicated
Resveratrol concentrations. qPCR was carried out as described in
[89]. C–E. Flow cytometry analysis of KLEC.219 (GFP positive)
for RFP expression. Cells were treated with Resveratrol or TPA at
the indicated dose and time period, or infected with the indicated
lentiviruses. The numbers denote the percentage of RFP positive
cells, which reflects lytic cells. F. Relative KSHV DNA copy
number in 293T cells infected using the growth media of BCBL1
cell infected with the indicated lentiviruses.
(TIF)
Table S1 KSHV miRNAs that are predicted by the PITA
algorithm to target EGLN2 or HSPA9 and found to down-
regulate the mRNA levels of these genes or to reduce
luciferase activity in 39UTR assay (shown in Figure 3C
and D).
(PDF)
Table S2 Cellular miRNAs which are predicted to target
EGLN2 according to the algorithm miRror [83].
(PDF)
Table S3 Cellular miRNAs which are predicted to target
all three HIF prolyl hydroxylase (EGLN1-3) according to
the algorithm miRror [83].
(PDF)
Table S4 List of primers used in this study.
(PDF)
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